Medicine raw material centrifugal differentiation equipment for resisting arterial congee sclerosis
By designing a centrifugal differentiation equipment for anti-artherosclerosis drug raw materials including magnetic balls, brushes and water pipes, the problem of incomplete separation caused by drug raw materials is solved, and a higher quality finished drugs are achieved.
Patent Information
- Application Number
- CN202421321016.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-11
- Publication Date
- 2025-03-11
- Estimated Expiration
- 2034-06-11
AI Technical Summary
During the use of existing anti-atherosclerosis drug raw materials, the drug raw materials are easily adsorbed on the side wall of the equipment, resulting in incomplete separation and affecting the quality of the finished drug.
A centrifugal differentiation device including a support assembly, a driving assembly, a stirring barrel and a stirring rod is designed to reduce adsorption and residue of drug raw materials by hitting the inner wall of the stirring barrel by magnetic balls, cleaning the surface of the stirring barrel, cleaning the inner wall of the stirring barrel, and spraying cleaning liquid on the water pipe.
It effectively reduces the adsorption of drug raw materials on the inner wall of the equipment, improves the thoroughness of separation, and thus improves the quality of finished drugs.
Smart Images
Figure CN222586256U_ABST
Abstract
Description
Technical Field
[0001] The utility model belongs to the technical field of drug processing, in particular to a centrifugal differentiation device for drug raw materials used for resisting atherosclerosis. Background Art
[0002] Atherosclerosis, also known as atherosclerosis, is a disease of the arterial wall and a very common type of arteriosclerotic disease.
[0003] There are many types of drug raw materials for anti-atherosclerosis, which roughly include three categories: antiplatelet drugs, anticoagulants and lipid-regulating drugs. These three types of drugs are Western medicines. In addition to Western medicines, Chinese medicine raw materials can also be used to treat atherosclerosis. Therefore, there are many types of drug raw materials for the treatment of atherosclerosis.
[0004] During long-term use and observation, it has been found in the existing centrifugal differentiation equipment for anti-atherosclerotic drug raw materials that during the centrifugal differentiation of the anti-atherosclerotic drug raw materials, the anti-atherosclerotic drug raw materials will be adsorbed on the side walls of the centrifugal differentiation equipment, resulting in incomplete separation of the drug raw materials, which ultimately affects the quality of the finished drug.
[0005] To this end, the utility model provides a centrifugal differentiation device for drug raw materials for resisting atherosclerosis. Utility Model Content
[0006] In order to make up for the deficiencies of the prior art, at least one technical problem raised in the background technology is solved.
[0007] The utility model solves the technical problem by adopting the following technical scheme: the utility model discloses a centrifugal differentiation device for drug raw materials for resisting atherosclerosis, comprising a support assembly; a driving assembly is fixedly connected to the side wall of the support assembly; the output end of the driving assembly extends to the inside of the support assembly; the top of the support assembly is connected to a stirring barrel; the output end of the driving assembly is located below the stirring barrel; a stirring rod is fixedly connected to the output end of the driving assembly; the stirring rod extends to the inside of the stirring barrel; a plurality of stirring blades are fixedly connected to the middle of the stirring rod; a limiting pad is fixedly connected to the top of the stirring rod; a collar is fixedly connected to the middle of the stirring rod; the collar is located below the limiting pad; a group of elastic ropes are fixedly connected to the bottom of the collar; a group of ends of the elastic ropes are fixedly connected to magnetic balls; a group of magnetic blocks are fixedly connected to the side wall of the stirring barrel; a group of magnetic blocks are symmetrically arranged, and through the above structure, the inner side wall of the stirring barrel can be knocked by the magnetic ball, thereby reducing the incomplete separation caused by the adsorption of the drug raw materials for resisting atherosclerosis on the inner side wall of the stirring barrel.
[0008] Preferably, the middle part of the stirring rod is slidably connected to a sliding ring; a group of elastic bands are fixedly connected to the top of the sliding ring; a group of ends of the elastic bands are fixedly connected to the middle part of the elastic rope; a plurality of first brushes are fixedly connected to the bottom of the sliding ring; the plurality of first brushes are equidistantly distributed along the circumference of the sliding ring and are in contact with the middle part of the stirring rod. Through the above structure, the adsorption of anti-atherosclerotic drug raw materials on the surface of the stirring rod can be reduced, thereby causing uneven separation of the anti-atherosclerotic drug raw materials, and ultimately leading to poor quality of the finished drug.
[0009] Preferably, the tops of the plurality of stirring blades are fixedly connected to a support rod; a plurality of groups of second brushes are fixedly connected to the middle of the support rod; the plurality of groups of second brushes are equidistantly distributed along the length of the support rod and are in contact with the side wall of the driving assembly. Through the above structure, the plurality of second brushes can clean the inner wall of the stirring barrel, thereby reducing the adsorption of the anti-atherosclerotic drug raw materials on the inner wall of the stirring barrel, which makes separation difficult.
[0010] Preferably, the side wall of the support assembly is fixedly connected to a water tank; the side wall of the water tank is connected to a water pipe; the end of the water pipe extends to the top of the stirring barrel. Through the above structure, the interior of the stirring barrel can be cleaned, thereby reducing the excessive residues of anti-atherosclerotic drug raw materials inside the stirring barrel, which will cause mutual fusion during the next separation.
[0011] Preferably, a fixing ring is fixedly connected to the middle part of the water pipe; a connecting rod is fixedly connected to the middle part of the fixing ring; the end of the connecting rod is fixedly connected to the side wall of the supporting assembly. Through the above structure, the fixing ring and the connecting rod can work together, thereby reducing the loosening of the water pipe caused by the shaking of the water pump for a long time, which ultimately makes it difficult to spray the cleaning liquid on the inside of the mixing barrel.
[0012] Preferably, a support plate is fixedly connected to the middle of the mixing barrel; a plurality of limit assemblies are fixedly connected to the middle of the mixing barrel; the magnetic block is located inside the limit assemblies; the bottom of the magnetic block contacts the top of the support plate. Through the above structure, the position of the magnetic block is offset when the magnetic ball is adsorbed by the magnetic block, which causes the magnetic block to fall off.
[0013] The beneficial effects of the utility model are as follows:
[0014] 1. The centrifugal differentiation device for anti-atherosclerotic drug raw materials described in the utility model uses a magnetic ball to knock the inner wall of the stirring barrel, thereby reducing the adsorption of the anti-atherosclerotic drug raw materials on the inner wall of the stirring barrel, resulting in incomplete separation.
[0015] 2. The centrifugal differentiation equipment for anti-atherosclerotic drug raw materials described in the utility model can continuously clean the middle part of the stirring rod through the first brush, thereby reducing the adsorption of anti-atherosclerotic drug raw materials on the surface of the stirring rod, thereby causing uneven separation of the anti-atherosclerotic drug raw materials, and ultimately resulting in poor quality of the finished drug. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] The utility model will be further described below in conjunction with the accompanying drawings.
[0017] Figure 1 It is a three-dimensional diagram of the utility model;
[0018] Figure 2 It is a structural schematic diagram of the utility model;
[0019] Figure 3 It is a structural schematic diagram of the utility model;
[0020] Figure 4 It is a structural schematic diagram of the utility model;
[0021] In the figure: 1. Support assembly; 12. Drive assembly; 13. Mixing barrel; 14. Mixing rod; 15. Mixing blade; 16. Ring; 17. Elastic rope; 18. Magnetic ball; 19. Magnetic block; 110. Limit pad; 2. Sliding ring; 21. Elastic belt; 22. First brush; 3. Support rod; 31. Second brush; 4. Water tank; 41. Water pipe; 5. Fixed ring; 51. Connecting rod; 6. Limit assembly; 61. Support plate; 7. Anti-slip pad. DETAILED DESCRIPTION
[0022] In order to make the technical means, creative features, objectives and effects achieved by the present invention easy to understand, the present invention is further described below in conjunction with specific implementation methods.
[0023] like Figures 1 to 4As shown, a centrifugal differentiation device for treating atherosclerosis of a drug raw material according to an embodiment of the utility model comprises a support assembly 1; a driving assembly 12 is fixedly connected to the side wall of the support assembly 1; an output end of the driving assembly 12 extends to the interior of the support assembly 1; a stirring barrel 13 is connected to the top of the support assembly 1; the output end of the driving assembly 12 is located below the stirring barrel 13; a stirring rod 14 is fixedly connected to the output end of the driving assembly 12; the stirring rod 14 extends to the interior of the stirring barrel 13; a plurality of stirring blades 15 are fixedly connected to the middle of the stirring rod 14; the stirring rod 14 The top of the stirring rod 14 is fixedly connected to a limit pad 110; the middle of the stirring rod 14 is fixedly connected to a collar 16; the collar 16 is located below the limit pad 110; the bottom of the collar 16 is fixedly connected to a group of elastic ropes 17; the ends of a group of elastic ropes 17 are fixedly connected to magnetic balls 18; the side wall of the stirring barrel 13 is fixedly connected to a group of magnetic blocks 19; a group of magnetic blocks 19 are symmetrically arranged. When working, the drive assembly 12 is started. As the drive assembly 12 is started, the output end of the drive assembly 12 will rotate. At this time, as the output end of the drive assembly 12 rotates, the stirring barrel 13 can be driven to rotate. At this time As the stirring barrel 13 rotates, the stirring blade 15 in the middle of the stirring rod 14 will also rotate synchronously, and the drug raw materials for resisting atherosclerosis can be separated at this time. At this time, as the stirring rod 14 rotates, the ring 16 in the middle of the stirring rod 14 will rotate synchronously. At this time, as the ring 16 rotates, the elastic rope 17 at the bottom of the ring 16 will also rotate synchronously. At this time, as the elastic rope 17 rotates, the magnetic ball 18 at the end of the elastic rope 17 can be driven to rotate. At this time, the rotating magnetic ball 18 will be continuously adsorbed by the magnetic block 19 on the side wall of the stirring barrel 13. As the magnetic block 19 continuously adsorbs the magnetic ball 18 The magnetic ball 18 is then continuously brought into contact with the inner wall of the mixing barrel 13, and the inner wall of the mixing barrel 13 is knocked. At this time, the anti-atherosclerotic drug raw materials adsorbed on the inner wall of the mixing barrel 13 will fall off as the magnetic ball 18 knocks on the inner wall of the mixing barrel 13. Through the above structure, the magnetic ball 18 can knock on the inner wall of the mixing barrel 13, thereby reducing the anti-atherosclerotic drug raw materials adsorbed on the inner wall of the mixing barrel 13, resulting in incomplete separation.
[0024] like Figure 2 and Figure 3As shown, the middle part of the stirring rod 14 is slidably connected with a sliding ring 2; a group of elastic bands 21 are fixedly connected to the top of the sliding ring 2; the ends of a group of the elastic bands 21 are fixedly connected to the middle part of the elastic rope 17; a plurality of first brushes 22 are fixedly connected to the bottom of the sliding ring 2; the plurality of first brushes 22 are equidistantly distributed along the circumference of the sliding ring 2 and contact the middle part of the stirring rod 14. When working, as the magnetic block 19 continuously adsorbs the magnetic ball 18, the elastic rope 17 will be deformed, and as the elastic rope 17 is deformed, the elastic band 21 will be deformed synchronously. At this time, as the elastic band 21 is pulled up by the elastic rope 17 and deformed, the sliding ring 2 can be driven to slide in the middle of the stirring rod 14. At this time, as the sliding ring 2 slides in the middle of the stirring rod 14, the first brush 22 at the bottom of the sliding ring 2 can be driven to slide continuously. At this time, the first brush 22 will continuously clean the middle of the stirring rod 14. Through the above structure, the surface adsorption of anti-atherosclerotic drug raw materials on the stirring rod 14 can be reduced, thereby causing uneven separation of the anti-atherosclerotic drug raw materials, and ultimately resulting in poor quality of the finished drug.
[0025] like Figure 2 and Figure 3 As shown, the tops of the plurality of stirring blades 15 are fixedly connected to a support rod 3; the middle part of the support rod 3 is fixedly connected to a plurality of groups of second brushes 31; the plurality of groups of second brushes 31 are equidistantly distributed along the length of the support rod 3 and are in contact with the side wall of the driving assembly 12. During operation, as the driving assembly 12 is started, the output end of the driving assembly 12 will drive the stirring rod 14 to rotate inside the stirring barrel 13. At this time, as the stirring blades 15 rotate, the support rod 3 at the top of the stirring blades 15 will rotate synchronously. At this time, as the support rod 3 rotates, the second brush 31 will also unfold with the rotation. At this time, the unfolded plurality of second brushes 31 will synchronously clean the inner wall of the stirring barrel 13. Through the above structure, the plurality of second brushes 31 can clean the inner wall of the stirring barrel 13, thereby reducing the adsorption of the anti-atherosclerotic drug raw materials on the inner wall of the stirring barrel 13, which makes it difficult to separate.
[0026] like Figure 1As shown, the side wall of the support assembly 1 is fixedly connected with a water tank 4; the side wall of the water tank 4 is connected with a water pipe 41; the end of the water pipe 41 extends to the top of the stirring barrel 13. During operation, after the anti-atherosclerotic drug raw materials are separated and taken out inside the stirring barrel 13, the cleaning liquid can be filled in the water tank 4, and then the water pump inside the water tank 4 is started. As the water pump is started, the cleaning liquid inside the water tank 4 will be filled into the water pipe 41, and the cleaning liquid will be sprayed into the inside of the stirring barrel 13 through the end of the water pipe 41. At this time, the driving assembly 12 is started again, and as the water pump is started, the cleaning liquid inside the water tank 4 will be filled into the water pipe 41. At this time, the cleaning liquid will be sprayed into the inside of the stirring barrel 13 through the end of the water pipe 41. At this time, the driving assembly 12 is started again. With the start of the driving component 12, the output end of the driving component 12 rotates again, thereby driving the stirring rod 14 to rotate. At this time, the rotating stirring rod 14 will drive the second brush 31 and the first brush 22 to rotate continuously. At this time, the second brush 31 and the first brush 22 will break up the cleaning liquid inside the stirring barrel 13, and the inside of the stirring barrel 13 can be cleaned. Through the above structure, the inside of the stirring barrel 13 can be cleaned, thereby reducing the excessive residues of the anti-atherosclerotic drug raw materials inside the stirring barrel 13, which will cause the next separation to merge with each other.
[0027] like Figure 1 As shown, a fixing ring 5 is fixedly connected to the middle of the water pipe 41; a connecting rod 51 is fixedly connected to the middle of the fixing ring 5; the end of the connecting rod 51 is fixedly connected to the side wall of the support assembly 1. During operation, as the water pump is started, the water pump will shake. At this time, as the water pump works for a long time, it will drive the water pipe 41 to shake synchronously. At this time, as time goes by, the long-term shaking of the water pipe 41 will cause it to loosen. At this time, a fixing ring 5 is installed in the middle of the water pipe 41, and then the fixing ring 5 and the side wall of the support assembly 1 are connected by the connecting rod 51. Through the above structure, the fixing ring 5 and the connecting rod 51 can work together, thereby reducing the loosening of the water pipe 41 caused by the long-term shaking of the water pump, which ultimately makes it difficult to spray the cleaning liquid on the inside of the mixing barrel 13.
[0028] like Figure 4 As shown, a support plate 61 is fixedly connected to the middle of the mixing barrel 13; a plurality of limit assembly 6 are fixedly connected to the middle of the mixing barrel 13; the magnetic block 19 is located inside the limit assembly 6; the bottom of the magnetic block 19 is in contact with the top of the support plate 61. When working, as the output end of the driving assembly 12 rotates, the stirring rod 14 will be driven to rotate synchronously. At this time, the rotating stirring rod 14 will drive the magnetic ball 18 to rotate continuously, thereby continuously adsorbing the magnetic block 19. At this time, the magnetic block 19 is fixed at a specified position through the cooperation of the limit assembly 6 and the support plate 61. Through the above structure, the position of the magnetic block 19 is offset when the magnetic ball 18 is adsorbed by the magnetic block 19, which causes the magnetic block 19 to fall off.
[0029] like Figure 1As shown, the bottom of the support component 1 is fixed with an anti-skid pad 7. Through the above structure, the anti-skid pad 7 can be installed at the bottom of the support component 1 to reduce the shaking of the driving component 12 during operation, thereby reducing the displacement and tilt of the equipment.
[0030] During operation, the driving assembly 12 is started. With the start of the driving assembly 12, the output end of the driving assembly 12 will rotate. At this time, with the rotation of the output end of the driving assembly 12, the stirring barrel 13 can be driven to rotate. At this time, with the rotation of the stirring barrel 13, the stirring blade 15 in the middle of the stirring rod 14 will also rotate synchronously. At this time, the drug raw materials for combating atherosclerosis can be separated. At this time, with the rotation of the stirring rod 14, the ring 16 in the middle of the stirring rod 14 will rotate synchronously. At this time, with the rotation of the ring 16, the elastic rope 17 at the bottom of the ring 16 will also rotate synchronously. At this time, with the rotation of the elastic rope 17, the magnetic ball 18 at the end of the elastic rope 17 can be driven to rotate. At this time, the rotating magnetic ball 18 will be continuously moved by the side of the stirring barrel 13 The magnetic block 19 on the wall is adsorbed. As the magnetic block 19 continuously adsorbs the magnetic ball 18, the elastic rope 17 is deformed, so that the magnetic ball 18 is constantly close to the inner wall of the mixing barrel 13. At this time, when the magnetic ball 18 is constantly in contact with the inner wall of the mixing barrel 13, the inner wall of the mixing barrel 13 can be knocked. At this time, the anti-atherosclerotic drug raw materials adsorbed on the inner wall of the mixing barrel 13 will fall as the magnetic ball 18 knocks on the inner wall of the mixing barrel 13. As the magnetic block 19 continuously adsorbs the magnetic ball 18, the elastic rope 17 is deformed. At this time, as the elastic rope 17 is deformed, the elastic belt 21 is synchronously driven to deform. At this time, as the elastic belt 21 is pulled up by the elastic rope 17 and deformed, the sliding ring 2 can be driven on the stirring rod 1 4 slides, and as the sliding ring 2 slides in the middle of the stirring rod 14, the first brush 22 at the bottom of the sliding ring 2 can be driven to slide continuously. At this time, the first brush 22 will continuously clean the middle of the stirring rod 14. As the driving component 12 is started, the output end of the driving component 12 will drive the stirring rod 14 to rotate inside the stirring barrel 13. At this time, as the stirring blade 15 rotates, the support rod 3 on the top of the stirring blade 15 will rotate synchronously. At this time, as the support rod 3 rotates, the second brush 31 will also be unfolded with the rotation. At this time, the unfolded multiple groups of second brushes 31 will synchronously clean the inner wall of the stirring barrel 13. When the anti-atherosclerotic drug raw materials are separated and taken out inside the stirring barrel 13 After that, the cleaning liquid can be filled in the water tank 4, and then the water pump in the water tank 4 is started. As the water pump is started, the cleaning liquid in the water tank 4 will be filled into the water pipe 41, and the cleaning liquid will be sprayed to the inside of the mixing barrel 13 through the end of the water pipe 41. At this time, the driving component 12 is started again. As the driving component 12 is started, the output end of the driving component 12 rotates again, thereby driving the stirring rod 14 to rotate. At this time, the rotating stirring rod 14 will drive the second brush 31 and the first brush 22 to rotate continuously. At this time, the second brush 31 and the first brush 22 will break up the cleaning liquid in the mixing barrel 13, and the inside of the mixing barrel 13 can be cleaned. As the water pump is started, the water pump will shake. At this time, as the water pump works for a long time,It will drive the water pipe 41 to shake synchronously. As time goes by, the water pipe 41 will become loose due to long-term shaking. At this time, by installing a fixing ring 5 in the middle of the water pipe 41, and then connecting the fixing ring 5 and the side wall of the support component 1 through a connecting rod 51, the stirring rod 14 will be driven to rotate synchronously with the rotation of the output end of the driving component 12. At this time, the rotating stirring rod 14 will drive the magnetic ball 18 to rotate continuously, thereby continuously adsorbing the magnetic block 19. At this time, the magnetic block 19 is fixed at a specified position through the cooperation of the limit component 6 and the support plate 61.
[0031] The above shows and describes the basic principles, main features and advantages of the utility model. Those skilled in the art should understand that the utility model is not limited by the above embodiments. The above embodiments and descriptions are only for explaining the principles of the utility model. Without departing from the spirit and scope of the utility model, the utility model may have various changes and improvements, which fall within the scope of the utility model to be protected. The scope of protection claimed by the utility model is defined by the attached claims and their equivalents.
Claims
1. A centrifugal differentiation device for anti-atherosclerotic drug raw materials, comprising a support assembly (1); characterized in that: A driving assembly (12) is fixedly connected to the side wall of the support assembly (1); the output end of the driving assembly (12) extends into the interior of the support assembly (1); the top of the support assembly (1) is connected to a stirring barrel (13); the output end of the driving assembly (12) is located below the stirring barrel (13); a stirring rod (14) is fixedly connected to the output end of the driving assembly (12); the stirring rod (14) extends into the interior of the stirring barrel (13); a plurality of stirring rods (14) are fixedly connected to the middle of the stirring rod (14). a stirring blade (15); the top of the stirring rod (14) is fixedly connected to a limiting pad (110); the middle of the stirring rod (14) is fixedly connected to a collar (16); the collar (16) is located below the limiting pad (110); the bottom of the collar (16) is fixedly connected to a group of elastic ropes (17); the ends of a group of the elastic ropes (17) are all fixedly connected to magnetic balls (18); the side wall of the stirring barrel (13) is fixedly connected to a group of magnetic blocks (19); the group of magnetic blocks (19) are symmetrically arranged.
2. The centrifugal differentiation device for the raw material of medicine for anti-atherosclerosis according to claim 1, characterized in that: The middle of the stirring rod (14) is slidably connected to a sliding ring (2); a group of elastic bands (21) are fixedly connected to the top of the sliding ring (2); the ends of a group of elastic bands (21) are fixedly connected to the middle of the elastic rope (17); a plurality of first brushes (22) are fixedly connected to the bottom of the sliding ring (2); the plurality of first brushes (22) are equidistantly distributed along the circumference of the sliding ring (2) and are in contact with the middle of the stirring rod (14).
3. The centrifugal differentiation device for the raw material of medicine for anti-atherosclerosis according to claim 2, characterized in that: The tops of the plurality of stirring blades (15) are all fixedly connected to a support rod (3); the middle of the support rod (3) is fixedly connected to a plurality of groups of second brushes (31); the plurality of groups of second brushes (31) are equidistantly distributed along the length of the support rod (3) and are in contact with the side wall of the driving component (12).
4. The centrifugal differentiation device for the raw material of medicine for anti-atherosclerosis according to claim 3, characterized in that: The side wall of the support assembly (1) is fixedly connected to a water tank (4); the side wall of the water tank (4) is connected to a water pipe (41); the end of the water pipe (41) extends to the top of the mixing barrel (13).
5. The centrifugal differentiation device for the raw material of medicine for anti-atherosclerosis according to claim 4, characterized in that: A fixing ring (5) is fixedly connected to the middle of the water pipe (41); a connecting rod (51) is fixedly connected to the middle of the fixing ring (5); and the end of the connecting rod (51) is fixedly connected to the side wall of the support assembly (1).
6. The centrifugal differentiation device for the raw material of medicine for anti-atherosclerosis according to claim 5, characterized in that: A support plate (61) is fixedly connected to the middle of the mixing barrel (13); a plurality of limit assemblies (6) are fixedly connected to the middle of the mixing barrel (13); the magnetic block (19) is located inside the limit assemblies (6); and the bottom of the magnetic block (19) is in contact with the top of the support plate (61).